Summary
The National Institutes of Health (NIH) is offering the Cutting-Edge Basic Research Awards (CEBRA) program under the R21 mechanism, which supports exploratory and developmental research projects. This funding opportunity encourages innovative, high-risk/high-reward basic research that may optionally include a clinical trial component. The program aims to foster novel scientific directions and preliminary investigations that could open new areas of biomedical inquiry. The opportunity is open from December 2024 through August 2027, allowing multiple submission cycles.